| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.45 | 0.001 |